PL371439A1 - Pochodne ftalimidu jako inhibitory monoaminoksydazy B - Google Patents

Pochodne ftalimidu jako inhibitory monoaminoksydazy B

Info

Publication number
PL371439A1
PL371439A1 PL03371439A PL37143903A PL371439A1 PL 371439 A1 PL371439 A1 PL 371439A1 PL 03371439 A PL03371439 A PL 03371439A PL 37143903 A PL37143903 A PL 37143903A PL 371439 A1 PL371439 A1 PL 371439A1
Authority
PL
Poland
Prior art keywords
inhibitors
monoamine oxidase
phthalimido derivatives
phthalimido
derivatives
Prior art date
Application number
PL03371439A
Other languages
English (en)
Inventor
Andrea Cesura
Sarmiento Rosa Maria Rodriguez
Andrew William Thomas
Rene Wyler
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL371439A1 publication Critical patent/PL371439A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL03371439A 2002-03-27 2003-03-20 Pochodne ftalimidu jako inhibitory monoaminoksydazy B PL371439A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02007222 2002-03-27

Publications (1)

Publication Number Publication Date
PL371439A1 true PL371439A1 (pl) 2005-06-13

Family

ID=28051746

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371439A PL371439A1 (pl) 2002-03-27 2003-03-20 Pochodne ftalimidu jako inhibitory monoaminoksydazy B

Country Status (13)

Country Link
US (2) US6660736B2 (pl)
EP (1) EP1490334A1 (pl)
JP (1) JP4202270B2 (pl)
KR (1) KR100592630B1 (pl)
CN (1) CN1277820C (pl)
AR (1) AR039122A1 (pl)
AU (1) AU2003226680B2 (pl)
BR (1) BR0308786A (pl)
CA (1) CA2477771A1 (pl)
MX (1) MXPA04009335A (pl)
PL (1) PL371439A1 (pl)
RU (1) RU2317289C2 (pl)
WO (1) WO2003080573A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846832B2 (en) * 2002-08-07 2005-01-25 Hoffman-La Roche Inc. 2,3-dihydro-isoindol-1-one derivatives
RU2006117366A (ru) * 2003-10-23 2007-12-10 Ф.Хоффманн-Ля Рош Аг (Ch) Производные бензазепина в качестве ингибиторов мао-в
US20070054347A1 (en) * 2005-02-22 2007-03-08 Mcgill University Oxidative stress measurement device and related methods
CA2598762A1 (en) 2005-02-25 2006-08-31 F. Hoffmann-La Roche Ag Tablets with improved drug substance dispersibility
TW200804347A (en) * 2006-01-10 2008-01-16 Janssen Pharmaceutica Nv Urotensin II receptor antagonists
CA2659412A1 (en) 2006-07-31 2008-02-07 Janssen Pharmaceutica N.V. Urotensin ii receptor antagonists
US8222243B2 (en) 2007-08-27 2012-07-17 Dart Neuroscience (Cayman) Ltd Therapeutic isoxazole compounds
ES2379762T3 (es) * 2008-08-02 2012-05-03 Janssen Pharmaceutica N.V. Antagonistas del receptor de la urotensina II
US20160362391A1 (en) * 2013-11-25 2016-12-15 Mylan Laboratories Ltd. Improved Process for the Preparation of Pomalidomide and its Purification
CN107709314A (zh) 2015-06-11 2018-02-16 巴斯利尔药物国际股份公司 外排泵抑制剂及其治疗性用途
CN106188039B (zh) * 2016-06-30 2019-01-01 广东工业大学 一种二酮衍生物及其制备方法与应用
CA3035999C (en) * 2017-09-07 2021-01-05 Syaulan S. YANG Benzene fused heterocyclic derivatives and pharmaceutical composition comprising the same
CN108752300B (zh) * 2018-05-16 2022-03-25 中国科学院昆明植物研究所 苄烯叉苯肽类化合物及其药物组合物和其应用
CN111072604B (zh) * 2018-10-18 2022-11-04 广东东阳光药业有限公司 α-氨基酰胺衍生物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524206A (en) 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
JPH04295470A (ja) 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−b酵素阻害活性を有する1,2,4−オキサジアゾール誘導体及びその製造法
TW219935B (pl) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
NZ291508A (en) * 1994-08-30 1999-07-29 Sankyo Co Isoxazoles; preparation and medicaments
US5679715A (en) 1995-06-07 1997-10-21 Harris; Richard Y. Method for treating multiple sclerosis
CA2244253C (en) 1996-03-15 2002-11-12 Somerset Pharmaceuticals, Inc. Method for preventing and treating peripheral neuropathy by administering selegiline
WO2001034172A2 (en) 1999-11-05 2001-05-17 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome

Also Published As

Publication number Publication date
JP4202270B2 (ja) 2008-12-24
EP1490334A1 (en) 2004-12-29
JP2005526796A (ja) 2005-09-08
AR039122A1 (es) 2005-02-09
MXPA04009335A (es) 2005-01-25
AU2003226680B2 (en) 2009-05-07
KR100592630B1 (ko) 2006-06-26
AU2003226680A1 (en) 2003-10-08
US20040229871A1 (en) 2004-11-18
US6903095B2 (en) 2005-06-07
RU2317289C2 (ru) 2008-02-20
RU2004131651A (ru) 2005-07-10
BR0308786A (pt) 2005-01-11
US20030195208A1 (en) 2003-10-16
WO2003080573A1 (en) 2003-10-02
CA2477771A1 (en) 2003-10-02
US6660736B2 (en) 2003-12-09
CN1277820C (zh) 2006-10-04
KR20040108688A (ko) 2004-12-24
CN1642911A (zh) 2005-07-20

Similar Documents

Publication Publication Date Title
EP1551801A4 (en) NOVEL GAMMA-LACTAMES AS INHIBITORS OF BETA-SECRETASE
EP1549316A4 (en) HAMMER OF TFGbeta
SI1492785T1 (sl) 2-hidroksi-3-heteroarilindolni derivati kot inhibitorji GSK3
PL370478A1 (pl) Pochodne aminoindazolu jako inhibitory kinaz białkowych
AU2003261434A8 (en) Iminothiazolidinones as inhibitors of hcv replication
IL236013A (en) Edamantyl acetamide derivatives as 11-beta-hydroxysteroid dehydrogenase enzyme inhibitors
AU2003256334A8 (en) Inhibitors of hcv upjohn company
IL169691A0 (en) Malonamide derivatives as gamma-secretase inhibitors
AU2003293356A8 (en) Dihydropyridinone derivatives as hne inhibitors
IL165055A0 (en) N-Acylminobenzene derivatives as selective monoamine oxidase b inhibitors
IS7509A (is) Þíoxantínafleiður sem mergperoxídasatálmar
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
IL172876A0 (en) Substituted arylthiourea derivatives useful as inhibitors of viral replication
AU2003290735A1 (en) Inhibitors of monoamine uptake
AU2003230392A8 (en) Beta-secretase inhibitors
PL372226A1 (pl) Pochodne pirydynoamidu jako inhibitory monoaminooksydazy (MAO-B)
ZA200409691B (en) Heterotricyclyl 6-alkylidene-penems as ß-lactamase inhibitors
PL373523A1 (pl) Indol-2-ony jako selektywne inhibitory cyklooksygenazy-2
AU2003295638A8 (en) Novel inhibitors of beta-lactamase
AU2003216848A1 (en) Deracemisation of amines
SI1487802T1 (sl) 2,3-diaril-pirazolidinski derivati kot inhibitorji encimov, ki razgrajujejo nevrotenzin
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
AU2003231527A8 (en) Novel derivatives of carnosic acid
GB0228482D0 (en) Inhibitors of monoamine uptake
IL169094A0 (en) 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)